Feature Channels: Addiction

Filters close
Released: 9-Jul-2024 4:05 PM EDT
Government of Canada Invests in National Coordination and Indigenous-Led Research on Effective Substance Use Interventions
Canadian Institutes of Health Research (CIHR)

Government of Canada invests in national coordination and Indigenous-led research on effective substance use interventions

Newswise:  Brain neurotransmitter receptor antagonist found to prevent opioid addiction in mice
8-Jul-2024 6:15 PM EDT
Brain neurotransmitter receptor antagonist found to prevent opioid addiction in mice
University of California, Los Angeles (UCLA), Health Sciences

New research led by UCLA Health has found a drug that treats insomnia works to prevent the addictive effects of the morphine opioids in mice while still providing effective pain relief.

Not for public release

This news release is embargoed until 8-Jul-2024 5:00 PM EDT Released to reporters: 2-Jul-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 8-Jul-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 8-Jul-2024 10:05 AM EDT
Pennsylvania's Opioid Prescriptions Plunge 38% After State Monitoring Program Implementation
The Rothman Orthopaedic Institute Foundation for Opioid Research and Education

In 2016, nearly 2 million opioid prescriptions were given to patients across the state. However, by the end of the study period in 2020, there was a 38 percent decrease in opioid prescriptions written, according to this study by Dr. Asif Ilyas.

1-Jul-2024 12:05 PM EDT
Experimental drug supercharges medicine that reverses opioid overdose
Washington University in St. Louis

Researchers at Washington University School of Medicine in St. Louis, with collaborators at the University of Florida and Stanford University, identified a compound that, in mice, makes naloxone much more effective at counteracting a drug overdose.

Released: 1-Jul-2024 5:05 AM EDT
The Supreme Court blocks Sackler Family Immunity
Newswise

The U.S. Supreme Court has blocked the Sackler family's bid for immunity from opioid-related lawsuits in a landmark decision. This ruling marks a pivotal moment in the ongoing opioid crisis, potentially reshaping how litigation against pharmaceutical companies is handled nationwide.

   
Newswise: UNC Health Researchers Present Preliminary Data on Weight Loss Drugs on Alcohol Addiction
Released: 27-Jun-2024 1:05 PM EDT
UNC Health Researchers Present Preliminary Data on Weight Loss Drugs on Alcohol Addiction
University of North Carolina School of Medicine

Christian Hendershot, PhD, associate professor of psychiatry and director of the Clinical and Translational Addiction Research Program at the UNC School of Medicine, presented early findings from the first completed randomized controlled trial of semaglutide for reducing alcohol consumption in heavy drinkers.

Released: 24-Jun-2024 9:05 AM EDT
Exploitation of supply chain monitoring loopholes fueled US opioid epidemic, study finds
Indiana University

New research from the Indiana University Kelley School of Business explains how pharmaceutical companies were able to saturate the country with massive quantities of opioids, despite efforts by the Drug Enforcement Administration to regulate their supply.

Newswise: Chilling discovery: Cold-sensing protein may pave the way for safer pain relief
18-Jun-2024 2:30 PM EDT
Chilling discovery: Cold-sensing protein may pave the way for safer pain relief
Arizona State University (ASU)

Research published in Science Advances traced the history of human’s ability to feel cold back to the molecular underpinnings of the cold and menthol sensor TRPM8 over hundreds of millions of years. The findings could lead to non-addictive pain medications, a crucial development given the opioid crisis.

13-Jun-2024 9:05 AM EDT
Increasing Use and Awareness of Oral Nicotine Pouches Detailed
Lombardi Comprehensive Cancer Center at Georgetown University

A rigorous, comprehensive synthesis of evidence from 62 studies related to the use of oral nicotine pouches by Georgetown University’s Lombardi Comprehensive Cancer Center scientists and colleagues provides a much-needed assessment of how these products could lead to potential harmful consequences if used by young people.

Newswise:Video Embedded firearms-and-mental-health-8-top-facts-to-know
VIDEO
Released: 14-Jun-2024 9:05 AM EDT
Firearms and mental health: 8 top facts to know
Michigan Medicine - University of Michigan

A video and story with insights from three mental health professionals with expertise in firearm injury prevention

Released: 13-Jun-2024 11:05 AM EDT
ADHD meds may help pregnant patients control opioid use disorder
Washington University in St. Louis

Researchers at Washington University School of Medicine in St. Louis found that pregnant people who took ADHD medications while also being treated for opioid use disorder continued to take medication to address their opioid use disorder about two months longer than patients who stopped taking ADHD medications.

Released: 13-Jun-2024 11:05 AM EDT
Researchers to Develop Predictive Model for Opioid Addiction in High-Risk Patients
UC San Diego Health

UC San Diego School of Medicine part of $50M initiative to use predictive AI to help fight opioid abuse.

Newswise: Clinical trial shows promising results in a two-drug combination that curbs methamphetamine use
7-Jun-2024 5:05 PM EDT
Clinical trial shows promising results in a two-drug combination that curbs methamphetamine use
University of California, Los Angeles (UCLA), Health Sciences

A clinical trial on a two-drug therapy for methamphetamine use disorder reduced use of the highly addictive drug for up to 12 weeks after initiation of treatment. To date there is no FDA-approved medication for it.

Newswise:Video Embedded researchers-find-flavor-restrictions-affect-tobacco-buyers-differently-depending-on-socioeconomic-status
VIDEO
Released: 6-Jun-2024 10:05 AM EDT
Researchers find flavor restrictions affect tobacco buyers differently depending on socioeconomic status
Virginia Tech

Restricting menthol flavor in cigarettes while making nicotine replacement therapy, such as a skin patch that can help ease withdrawal, more available and affordable has the potential to reduce socioeconomic disparities in tobacco use.

Newswise: Cannabis use common among patients, with most using it to manage a symptom or health condition
4-Jun-2024 5:05 PM EDT
Cannabis use common among patients, with most using it to manage a symptom or health condition
University of California, Los Angeles (UCLA), Health Sciences

Nearly one in six patients in primary care reported cannabis use, with 35% of those using at levels indicating moderate- to high-risk use disorder. The findings indicate the need for routine cannabis use screening. Currently few healthcare systems offer this screening in primary care settings.

31-May-2024 9:05 AM EDT
Stopping a spreading fire: identifying connections between adverse childhood events and substance use disorders
Perelman School of Medicine at the University of Pennsylvania

Physical and sexual abuse, having parents who misuse substances, and witnessing violent crime are tragic events that don’t remain locked in a single point in time. Rather, they are termed adverse childhood experiences (ACEs) and 64 percent of American adults who participated in a recent survey reported experiencing at least one ACE prior to turning 18 years old.

   
Newswise: Increased risk of homelessness for youths growing up in foster homes
Released: 3-Jun-2024 7:05 PM EDT
Increased risk of homelessness for youths growing up in foster homes
University of South Australia

New research from the University of South Australia (UniSA) and Curtin University finds that up to 36% of young people leaving foster homes in Australia wind up homeless – compared to less than 10% of the general youth population.

Newswise: Retrospective Study Based on Electronic Health Records Finds Popular Diabetes and Weight-Loss Drugs Associated with Reduction in Incidence and Recurrence of Alcohol-Use Disorder by at Least Half
Released: 3-Jun-2024 9:00 AM EDT
Retrospective Study Based on Electronic Health Records Finds Popular Diabetes and Weight-Loss Drugs Associated with Reduction in Incidence and Recurrence of Alcohol-Use Disorder by at Least Half
Case Western Reserve University

A new study by researchers at the Case Western Reserve University School of Medicine reveals that the popular diabetes and weight-loss drugs Wegovy and Ozempic are linked to reduced incidence and recurrence of alcohol abuse or dependence.



close
2.49067